A major limitation of the treatment for ESRD has been, and continues to be, the shortfall in available donor organs; this situation has fostered greater interest in the areas of regenerative medicine and bioengineered organ substitutes. Among all solid organs, the kidney represents one of the most complex targets for tissue engineering due to its highly specialized microarchitecture, dense vascularization, and integrated filtration and excretory functions. Recent advances in decellularization–recellularization technologies have demonstrated the feasibility of generating bioengineered kidneys capable of limited physiological function in preclinical models. This narrative review critically examines progress in kidney bioengineering, with particular emphasis on scaffold-based regeneration strategies, cellular repopulation approaches, bioreactor conditioning, and experimental transplantation outcomes. Animal studies have shown that acellular renal scaffolds prepared from native organs can maintain extracellular matrix cues that support cell adhesion, differentiation, and vascular reconstruction. Recellularization with endothelial and renal epithelial cells has allowed for partial restoration of filtration and urine production following orthotopic transplantation in rodent models. Although functional output remains substantially lower than that of native kidneys, even modest renal activity may have meaningful clinical implications for patients dependent on dialysis. This review synthesizes current experimental findings, discusses methodological limitations, and evaluates translational challenges, including immune compatibility, long-term graft viability, and scalability for human application. By integrating biological, engineering, and clinical perspectives, the paper highlights bioengineered kidneys as a promising yet evolving strategy that may one day complement or transform conventional renal replacement therapies.

Chronic kidney disease and ESRD represent a growing worldwide health burden, for which millions of patients depend on dialysis or kidney transplantation for survival. While transplantation has superior outcomes compared to dialysis, its widespread application is hampered by the scarcity of donor organs and by the risk of immune rejection [1,2]. These limitations have accelerated research into regenerative strategies capable of producing functional renal tissue ex vivo. Kidney tissue engineering endeavors to replace the organ's complex structural and functional characteristics, including glomerular filtration, tubular reabsorption, vascular perfusion, and urinary drainage [3]. Early approaches utilizing cell aggregates or synthetic scaffolds showed limited success, highlighting the need for biomimetic frameworks emulating native renal architecture more closely [4]. Decellularized organ scaffolds have emerged as a promising platform, preserving ECM while eliminating immunogenic cellular components [5]. This review describes the evolution of bioengineered kidney development, summarizes experimental results, and considers the translational possibilities of this technology.

Literature Review

Initial approaches to renal regeneration utilized the differentiation of stem cells into organoids, providing insight into nephrogenesis but limited functional incorporation [6,7]. Whole-organ decellularization represented a paradigm shift, wherein researchers could maintain native ECM composition, vascular channels, and three-dimensional geometry [8]. It has been demonstrated that decellularized renal scaffolds maintain biochemical signals critical for endothelial and epithelial cell attachment and maturation [9]. Subsequent recellularization experiments using primary renal cells, endothelial progenitors, or induced pluripotent stem cell–derived lineages demonstrated partial reconstruction of nephron-like structures [10–12]. Additional use of bioreactor systems, which provide controlled perfusion and oxygenation, enhanced cell survival and functional differentiation [13]. Experimental transplantation of recellularized kidneys in rodent models provided proof of concept, with evidence of blood perfusion and urine production [14]. Despite advances in this field, challenges persist regarding cell sourcing, incomplete coverage of nephrons, thrombosis, and long-term functional stability [15–17].

Research Methodology

This narrative review was performed by a structured literature search of the PubMed, Scopus, and Web of Science databases for publications between 2005 and 2024. The keywords used in this study were "bioengineered kidney," "renal decellularization," "recellularization," and "organ regeneration." Original experimental and review articles related to scaffold-based kidney engineering in peer-reviewed journals were included. Extracted data comprised scaffold preparation, cell types used, bioreactor conditions, transplantation models, and their functional outcomes. More emphasis was given to preclinical animal studies with physiological renal activity.

Statistical Analysis

As this study represents a narrative synthesis rather than a meta-analysis, no pooled statistical modeling was performed. The reported functional outcomes, such as urine production rates and perfusion efficiency, are qualitatively compared across studies. Where available, original statistical methods from cited experimental studies were evaluated to assess robustness and reproducibility.

In various preclinical studies, decellularized kidney scaffolds showed preservation of ECM integrity and vascular patency. Recellularization with endothelial cells further enhanced perfusion and reduced thrombogenicity, while limited filtration and urine formation were achieved by renal epithelial cells. The transplantation of bioengineered kidneys resulted in approximately 5-10% of native renal function in rodent models, thus showing feasibility but highlighting further optimization.

Table 1: Key Experimental Milestones in Bioengineered Kidney Research

Table 2: Advantages and Limitations of Bioengineered Kidneys Compared with Conventional Therapies

Figure 1: Conceptual Workflow of Bioengineered Kidney Development

Source:Created by Haider et al 2025

Figure 2: Functional Integration of a Bioengineered Kidney After Transplantation

Source: Created by Haider et al 2025

This achievement shows that bioengineered kidneys have the potential for core physiological performances, marking a critical landmark in regenerative medicine. Though current levels of function are inadequate for full renal replacement, even partial activity might confer clinical benefit by reducing dependency on dialysis. Scaling the technology for human-sized organs, appropriate and consistent cell distribution, and graft survival through the long term are major issues that remain to be overcome in translation. These may be solved by advancements in stem cell biology, gene editing techniques, and bioreactor design.

This basically refers to the final thoughts on everything that might have been covered in the main body of the project work.

Bioengineered kidneys produced via decellularization–recellularization strategies are a promising avenue toward filling the organ donor gap. However, while human application remains in the highericí future, continued interdisciplinary research could finally achieve clinically viable, patient-specific renal grafts matching existing renal replacement therapies.

Acknowledgment:

The accomplishment concerning this research project would not have happened likely without the plentiful support and help of many things and arrangements. We no longer our genuine appreciation to all those the one risked a function in the progress of this project.

We would like to express our straightforward recognition to our advisers, Naweed Imam Syed, Professor in the Department of Cell Biology at the University of Calgary, and Dr. Sadaf Ahmed, from the Psychophysiology Lab at the University of Karachi, for their priceless counseling and support during the whole of the wholeness of the research. Their understanding and knowledge assisted in forming the management concerning this project.

Declaration of Interest:                        

I herewith acknowledge that:                                        

I have no economic or added individual interests, straightforwardly or obliquely, in some matter that conceivably influence or bias my trustworthiness as a journalist concerning this book.

Conflicts of Interest:

The authors profess that they have no conflicts of interest to reveal.

Financial Support and Protection:

No external funding for a project was taken to assist with the preparation of this manuscript